Dichloroacetate alleviates development of collagen II-induced arthritis in female DBA/1 mice

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Bian, Li ^a   Josefsson, Elisabet ^a   Jonsson, Ing Marie ^a   Verdrengh, Margareta ^a   Ohlsson, Claes ^b   Bokarewa, Maria ^a   Tarkowski, Andrej ^a   Magnusson, Mattias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUYDCA; DICHLOROACETIC ACID; ESTROGEN; UNCLASSIFIED DRUG; AUTOANTIBODY; COLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERAL; CARTILAGE DEGENERATION; COLLAGEN TYPE II INDUCED ARTHRITIS; CONTROLLED STUDY; CORTICAL BONE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GRANULOCYTE; JOINT DESTRUCTION; MALE; MOUSE; NONHUMAN; OSTEOLYSIS; RHEUMATOID ARTHRITIS; SHAM PROCEDURE; T LYMPHOCYTE; ANIMAL; ARTHRITIS; BLOOD; BONE DENSITY; DBA MOUSE; DELAYED HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; OVARIECTOMY; PATHOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BONE DENSITY; COLLAGEN; DICHLOROACETATE; ESTROGENS; FEMALE; HYPERSENSITIVITY, DELAYED; MICE; MICE, INBRED DBA; OVARIECTOMY; T-LYMPHOCYTES;

EID: 75649122284     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2799     Document Type: Article

References (43)

1. Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007, 11:37-51. 10.1016/j.ccr.2006.10.020, 17222789.
2. Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders MI. Amplifying elements of arthritis and joint destruction. Ann Rheum Dis 2007, 66(Suppl 3):iii45-48. 10.1136/ard.2007.079830, 17934095.
3. D'Elia HF, Larsen A, Mattsson LA, Waltbrand E, Kvist G, Mellstrom D, Saxne T, Ohlsson C, Nordborg E, Carlsten H. Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis. J Rheumatol 2003, 30:1456-1463.
4. Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983, 12:69-72. 10.3109/03009748309102886, 6857175.
5. Holmdahl R, Jansson L, Andersson M. Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum 1986, 29:1501-1509. 10.1002/art.1780291212, 3801072.
6. Yamasaki D, Enokida M, Okano T, Hagino H, Teshima R. Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis. Bone 2001, 28:634-640. 10.1016/S8756-3282(01)00426-4, 11425652.
7. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545. 10.1172/JCI36389, 2575731, 18982160.
8. Segal B, Rhodus NL, Patel K. Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008, 106:778-787. 10.1016/j.tripleo.2008.07.025, 18930662.
9. Blanchard F, Duplomb L, Baud'huin M, Brounais B. The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev 2009, 20:19-28. 10.1016/j.cytogfr.2008.11.004, 19038573.
10. Haynes DR. Inflammatory cells and bone loss in rheumatoid arthritis. Arthritis Res Ther 2007, 9:104. 10.1186/ar2213, 2206339, 17601357.
11. Okunishi K, Dohi M, Fujio K, Nakagome K, Tabata Y, Okasora T, Seki M, Shibuya M, Imamura M, Harada H, Tanaka R, Yamamoto K. Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol 2007, 179:5504-5513.
12. Cho YG, Cho ML, Min SY, Kim HY. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev 2007, 7:65-70. 10.1016/j.autrev.2007.08.001, 17967728.
13. Ferrándiz ML, Maicas N, Garcia-Arnandis I, Terencio MC, Motterlini R, Devesa I, Joosten LA, Berg WB, Alcaraz MJ. Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis. Ann Rheum Dis 2008, 67:1211-1217. 10.1136/ard.2007.082412, 18063671.
14. Brand DD, Kang AH, Rosloniec EF. Immunopathogenesis of collagen arthritis. Springer Semin Immunopathol 2003, 25:3-18. 10.1007/s00281-003-0127-1, 12904888.
15. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998, 19:37-44. 10.1016/S0167-5699(97)01186-9, 9465487.
16. Black CA. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol Online J 1999, 5:7.
17. Carlsten H, Nilsson LA, Tarkowski A. Impaired cutaneous delayed-type hypersensitivity in autoimmune MRL lpr/lpr mice. Int Arch Allergy Appl Immunol 1986, 81:322-325. 10.1159/000234156, 3491052.
18. Carlsten H, Holmdahl R, Tarkowski A, Nilsson LA. Oestradiol suppression of delayed-type hypersensitivity in autoimmune (NZB/NZW)F1 mice is a trait inherited from the healthy NZW parental strain. Immunology 1989, 67:205-209. 1385258, 2753520.
19. Carlsten H, Verdrengh M, Taube M. Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice. Inflamm Res 1996, 45:26-30. 10.1007/BF02263501, 8821775.
20. Josefsson E, Carlsten H, Tarkowski A. Neutrophil mediated inflammatory response in murine lupus. Autoimmunity 1993, 14:251-257. 10.3109/08916939309077373, 8329562.
21. Owens JW, Ashby J. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: in support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit Rev Toxicol 2002, 32:445-520. 10.1080/20024091064291, 12487363.
22. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm Res 2003, 52:341-346. 10.1007/s00011-003-1182-8, 14504672.
23. Bremell T, Abdelnour A, Tarkowski A. Histopathological and serological progression of experimental Staphylococcus aureus arthritis. Infect Immun 1992, 60:2976-2985. 257262, 1612762.
24. Abdelnour A, Arvidson S, Bremell T, Ryden C, Tarkowski A. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect Immun 1993, 61:3879-3885. 281089, 8359909.
25. Jonsson IM, Verdrengh M, Brisslert M, Lindblad S, Bokarewa M, Islander U, Carlsten H, Ohlsson C, Nandakumar KS, Holmdahl R, Tarkowski A. Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci USA 2007, 104:258-263. 10.1073/pnas.0608620104, 1765445, 17185416.
26. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999, 104:895-901. 10.1172/JCI6730, 408552, 10510330.
27. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol 2001, 167:4710-4718.
28. Tarkowski A, Czerkinsky C, Nilsson LA. Detection of rheumatoid factor within immunoglobulin classes. Monogr Allergy 1989, 26:1-17.
29. Rudolphi U, Rzepka R, Batsford S, Kaufmann SH, Mark K, Peter HH, Melchers I. The B cell repertoire of patients with rheumatoid arthritis. II. Increased frequencies of IgG+ and IgA+ B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue. Arthritis Rheum 1997, 40:1409-1419. 10.1002/art.1780400808, 9259420.
30. Park JH, Lee JM, Kim SN, Lee SH, Jun SH, You JH, Ahn KS, Kang H. Treatment with SI00 a new herbal formula, ameliorates murine collagen-induced arthritis. Biol Pharm Bull. 2008, 31:1337-1342. 10.1248/bpb.31.1337, 18591771.
31. Liljander M, Andersson A, Holmdahl R, Mattsson R. Increased susceptibility to collagen-induced arthritis in female mice carrying congenic Cia40/Pregq2 fragments. Arthritis Res Ther 2008, 10:R88. 10.1186/ar2470, 2575638, 18684326.
32. Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985, 82:5490-5494. 10.1073/pnas.82.16.5490, 391148, 2410927.
33. Kopf M, Herren S, Wiles MV, Pepys MB, Kosco-Vilbois MH. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med 1998, 188:1895-1906. 10.1084/jem.188.10.1895, 2212418, 9815267.
34. Suematsu S, Matsuda T, Aozasa K, Akira S, Nakano N, Ohno S, Miyazaki J, Yamamura K, Hirano T, Kishimoto T. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 1989, 86:7547-7551. 10.1073/pnas.86.19.7547, 298102, 2798426.
35. Jansson L, Holmdahl R. Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect. J Reprod Immunol 1989, 15:141-150. 10.1016/0165-0378(89)90033-8, 2769647.
36. Jochems C, Islander U, Erlandsson M, Verdrengh M, Ohlsson C, Carlsten H. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther 2005, 7:R837-843. 10.1186/ar1753, 1175035, 15987485.
37. Jochems C, Islander U, Kallkopf A, Lagerquist M, Ohlsson C, Carlsten H. Role of raloxifene as a potent inhibitor of experimental postmenopausal polyarthritis and osteoporosis. Arthritis Rheum 2007, 56:3261-3270. 10.1002/art.22873, 17907171.
38. Nandakumar KS, Holmdahl R. Collagen antibody induced arthritis. Methods Mol Med 2007, 136:215-223. full_text, 17983151.
39. Morgan K, Clague RB, Shaw MJ, Firth SA, Twose TM, Holt PJ. Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum 1981, 24:1356-1362. 10.1002/art.1780241104, 7317113.
40. Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K, Nomura S, Kopf M, Katada Y, Tanaka T, Suemura M, Kishimoto T. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci USA 1998, 95:8222-8226. 10.1073/pnas.95.14.8222, 20957, 9653168.
41. Lorentzon M, Mellstrom D, Ohlsson C. Association of amount of physical activity with cortical bone size and trabecular volumetric BMD in young adult men: the GOOD study. J Bone Miner Res 2005, 20:1936-1943. 10.1359/JBMR.050709, 16234966.
42. Rico H, Gonzalez-Riola J, Revilla M, Villa LF, Gomez-Castresana F, Escribano J. Cortical versus trabecular bone mass: influence of activity on both bone components. Calcif Tissue Int 1994, 54:470-472. 10.1007/BF00334325, 8082048.
43. Stacpoole PW, Kerr DS, Barnes C, Bunch ST, Carney PR, Fennell EM, Felitsyn NM, Gilmore RL, Greer M, Henderson GN, Hutson AD, Neiberger RE, O'Brien RG, Perkins LA, Quisling RG, Shroads AL, Shuster JJ, Silverstein JH, Theriaque DW, Valenstein E. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children. Pediatrics 2006, 117:1519-1531. 10.1542/peds.2005-1226, 16651305.